A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy for people who need alternatives to traditional treatment approaches; about 50% of adults with diabetes will develop peripheral neuropathy

AGC Biologics tapped to produce long-awaited diabetes drug

HHS report finds Inflation Reduction Act’s US$35 cap on month’s supply of insulin would have saved people with Medicare about US$500 on their insulin costs in 2020; the Act’s insulin provision went into effect January 1, 2023 for Medicare Part D

AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy

AGC Biologics Supports Commercial Production of Provention Bio’s New Type 1 Diabetes (T1D) Therapy, TZIELD™

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count